Enterprise League logo
argenx Logo

argenx

Rotterdam, The Netherlands · Health and Medical

Do you work at argenx?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#Oncology

#Autoimmune diseases

#Rare Diseases

#Antibody based medicines

#Immunotherapy

#Myasthenia Gravis

#Immunology

#Pemphigus Vulgaris

#Immune Thrombocytopenia

#Acute Myeloid Leukemia

argenx is a Health and Medical company based in Rotterdam, The Netherlands, founded in 2008, with 500-1000 employees. argenx's profile is verified on Enterprise League.

Overview

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx’s first experimental medicine, efgartigimod, is being evaluated in multiple autoimmune diseases, including myasthenia gravis (MG), pemphigus vulgaris (PV), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). argenx is located in Ghent, Belgium, Boston, Massachusetts and Tokyo, Japan.
Visit Official Website

Most teams do this before shortlisting

Contact Details

info@argenx.com

Rotterdam, The Netherlands

Founded

2008

Employees

500-1000

Categories

Clinical Trials
Biotechnology
Therapeutics

Keywords

#Oncology

#Autoimmune diseases

#Rare Diseases

#Antibody based medicines

#Immunotherapy

#Myasthenia Gravis

#Immunology

#Pemphigus Vulgaris

#Immune Thrombocytopenia

#Acute Myeloid Leukemia

Awards

• 2026 OpenSee all

Companies teams usually look at after argenx

Comparing a few options usually leads to better decisions

  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.